10,000 genomes scoured for clues to rare brain diseases
NCT ID NCT06072079
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will analyze DNA from 10,000 people with suspected rare genetic disorders affecting the brain. Researchers will map structural changes in chromosomes to find which genes cause disease. The goal is to improve genetic diagnosis and lay groundwork for future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could improve genetic testing and point toward new treatments for rare brain disorders.
- What could go wrong
- This is an observational study, not a treatment trial. It may take years to translate findings into therapies, and not all genetic changes found will be disease-causing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHROMOSOME ABNORMALITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anna Lindstrand
Stockholm, 19175, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One-shot gene editor aims to correct a brain disorder at its source
- Hackathon for the undiagnosed: mayo clinic launches repository to crack rare disease cases
- Massive global registry aims to unlock secrets of rett syndrome
- Biobank aims to unlock genetic secrets of rare diseases
- AI could shorten the long road to a rare disease diagnosis
- Blood bank aims to predict leukemia risk in MDS patients